ArticleExperimental hematology & oncology2022

Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells.

Bingqing Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.